House of Commons
As this motion is using historical data, we may not have the record of the original ordering, in which case signatories are listed alphabetically.
TAMIFLU
EDM #669
Tabled 20 January 2010
2009-10 Session
That this House is concerned at the mass use of the drug Tamiflu; notes that the US Food and Drugs Administration has warned of fatal side-effects including heart attacks; is surprised by the report in the British Medical Journal that the data on nine of the 10 trials of Tamiflu has not been published, verified or peer-reviewed and that the drug has not been shown to prevent influenza complications; is concerned by the conclusion of Professor Nick Freemantle that the beneficial treatment effects of Tamiflu is vanishingly small; and believes it is unwise to continue with the vaccination programme because of the uncertain knowledge of the safety and efficacy of Tamiflu.